Tprds News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PRDS | Complete Pardes Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

By Chris Wack Pardes Biosciences said Monday that it is being bought by MediPacific for a price per share of not less than $2.02 in cash and an additional...

Pardes Biosciences (NASDAQ:PRDS – Get Free Report) and Bellerophon Therapeutics (NASDAQ:BLPH – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings. Earnings and Valuation This table compares Pardes […]

Pardes Biosciences, Inc. (NASDAQ:PRDS – Get Free Report) was the target of a large drop in short interest in June. As of June 30th, there was short interest totalling 1,120,000 shares, a drop of 45.1% from the June 15th total of 2,040,000 shares. Based on an average daily trading volume, of 219,200 shares, the days-to-cover […]

BML Capital Management LLC purchased a new stake in shares of Pardes Biosciences, Inc. (NASDAQ:PRDS – Get Rating) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 4,867,984 shares of the company’s stock, valued at approximately $8,227,000. Pardes Biosciences makes up approximately 7.9% of […]